Drug
Fluticasone Furoate
Fluticasone Furoate: highest development phase Approved, developed by GlaxoSmithKline. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| FLUTICASONE FUROATE ELLIPTA | Approved |
Latest
- Exclusivity ends 2026-03-01 (application 205625)
Follow Fluticasone Furoate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.